Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects

NCT01527643 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novo Nordisk A/S